Adam Gahtan

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Bronze - Individuals: litigation

Few firms have as mature an understanding of the technology world as Fenwick & West. By the side of cutting-edge companies at every stage of their innovation and business journey, the Silicon Valley native understands the potency of intellectual property as a commercial tool and how to harness it for maximum gain. This is a gift of Daniel Brownstone, a long-time member who acts as primary patent counsel to a ride-sharing service and an investment bank – both famous names with valuable IP holdings. Turning to litigation, Fenwick & West has come on in leaps and bounds in New York in recent years, as Jeffrey Oelke, Kevin McGann, James Trainor and Adam Gahtan – who joined as a redoubtable strike force in 2018 – quickly settled into their groove. Staying up on his grind, Oelke has been putting in the shifts for a leading global healthcare concern and a prestigious pharmaceutical company, showcasing his persuasiveness in trial and post-grant settings in the process. Sources appreciate his “open and honest dialogue, trustworthy legal assessments and willingness to go the extra mile and add value”. McGann and Trainor have also seen plenty of life sciences action, handling multiple matters for UCB and Lohmann Therapie-Systeme; in one case, they obtained a Federal Circuit-affirmed verdict of infringement under the doctrine of equivalents, having replaced prior counsel two years into the litigation and just four months before trial. Gahtan was also central to this result, as Fenwick’s appellate mastermind. Although life sciences work has been the dominant feature of their practices of late, none of these lawyers can be pigeonholed – which is a measure of the transferability of their refined trial skills.

Get unlimited access to all IAM content